Notes on the First Public FDA Meeting on CBD

Last Friday, May 31, the Food and Drug Administration (“FDA”) held its first public meeting during which stakeholders shared their perspective on how to regulate cannabidiol (“CBD”)-infused products. The objective of the meeting was to gather scientific data and information about the safety, manufacturing, product quality, marketing, labeling and sale of these products. As we…

Read more
Removing Roadblocks in the Hemp Industry Six Months after the 2018 Farm Bill
Nearly six months have passed since the 2018 Farm Bill was enacted on December 20, 2018, but the road to developing a successful business in the hemp industry is still filled with roadblocks. Some of these obstacles are becoming easier to navigate, but we’re still a long way from... Read more
Member Blog: How To Build A Successful Hemp CBD Company
by Christie Lunsford, The Hemp Biz Conference The legalization of industrial hemp in December, 2018, has opened the door to a host of new products and processes that have the potential to enhance health and technological innovation while being environmentally sustainable and most importantly, highly profitable. Entrepreneurs who want to... Read more
NCIA Submits Public Comment To FDA On Hemp and CBD Products
Today, NCIA responded and submitted public comments to the U.S. Food and Drug Administration’s (FDA) request for comments on Scientific Data and Information About Products Containing Cannabis or Cannabis-Derived Compounds. Given the substantial interest in this topic and the need for regulations and standardization throughout the industry, NCIA and... Read more
TSA (Sort of) Allows (Some) Hemp-CBD Products on Flights

In the past few months, our team has been quoted in several magazines and online publications on the risks of traveling with CBD products. These media inquiries resulted from repeated arrests of travelers in possession of CBD oil at the Dallas/Fort Worth International Airport (“DFW”). At the time of these arrests, the Transportation Security Administration…

Read more
USDA Says States Should Not Interfere With Hemp Transportation

On May 28th, 2018, the United States Department of Agriculture (“USDA”) issued a non-binding opinion letter regarding hemp production (“USDA Letter“). The USDA’s Office of General Counsel (a.k.a., the USDA’s lawyer) made four conclusions in the letter, which I’ll explore in this post. 1. As of the enactment of the 2018 Farm Bill on December…

Read more
Oregon Hemp: The Permanent Rules Are Now In Effect

While Oregon legalized hemp production in 2015, the Beaver State has seen a huge influx of hemp grower and handler registrations since the enactment of the 2018 Farm Bill, which legalized hemp under federal law. To keep up with the growing interest in the crop and its derivatives, the Oregon Department of Agriculture (“ODA”) has…

Read more
USPTO Issues Clarification on Hemp-Related Trademarks

Earlier this month, the United States Patent and Trademark Office (USPTO) issued Examination Guide 1-19: Examination of Marks for Cannabis and Cannabis-Related Goods and Services After Enactment of the 2018 Farm Bill. While the guide didn’t provide any earth-shattering news regarding cannabis-related trademarks, it did clarify the USPTO’s position with respect to trademarks for domestic…

Read more
Cannabis and International Trade: Don’t Ignore the U.S.-China Trade War

Marijuana and hemp companies should not ignore the US-China trade war. Numerous products and components in these industries might be subject to increased tariffs of 25 percent. If cannabis companies can’t find new suppliers, those are costs that they will have to bear, or will have to pass on to their consumers. The Office of…

Read more
Emerald Health Therapeutics Introduces Unique Premium CBD Oil SYNC 25 to British Columbia Recreational Marketplace
Ryan Allway May 17th, 2019 App, News, Top News Emerald’s ultra-pure SYNC 25 CBD oil fills significant need in BC’s recreational marketplace, offering a non-THC, smoke-free alternative VANCOUVER, British Columbia, May 17, 2019 (GLOBE NEWSWIRE) — Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has shipped 6,000 40... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )